https://www.perspireip.com/news/uspto-issue-fee-to-grant-wait-doubles-60-days-continuation-ids-window/ PerspireIP en 2026-10-26T06:49:50+00:00 USPTO Issue Fee to Grant Now Runs 60 Days: What the Backlog Moves on Your Calendar https://www.perspireip.com/news/ptab-new-ground-of-rejection-ex-parte-lowder-gross-indefiniteness-printed-matter/ PerspireIP en 2026-10-25T06:49:04+00:00 PTAB New Ground of Rejection: Claims the Examiner Never Touched, on a Two-Month Clock https://www.perspireip.com/news/delhi-high-court-daplogin-cancelled-bevatas-pharmaceutical-trademark-similarity-india/ PerspireIP en 2026-10-24T06:51:22+00:00 Pharmaceutical Trademark Similarity Cuts Both Ways: Delhi HC Cancels DAPLOGIN, Clears BEVATAS